explore -WSS

explore

author：explore 2025-09-14 21:44:38 - browse：7

Sterile capsules for injection line up in a dispensing line — politics coverage from STAT — Adobe

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs.

Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists. Shortages are primarily a problem for hospitals and doctors who regularly administer drugs, including oncologists who have been running out of common chemo drugs. Generic injectables account for 67% of shortages, and more than half of drugs in short supply cost less than $1 per unit, according to the Finance Committee.

Hospitals band together to negotiate drug prices by hiring group purchasing organizations. The biggest three GPOs are estimated to control about 90% of the market for drugs that hospitals buy. Finance Chair Ron Wyden (D-Ore.) said those GPOs can drive prices down so low that manufacturers stop making certain drugs or can’t afford to maintain their facilities, which then leads to manufacturing interruptions. Drugmakers also say GPOs can also be fickle, switching from one manufacturer to another over small savings, leaving drugmakers without the certainty they need to commit to making large volumes of product.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

leisure time

WSS

What we know about the American soldier detained in North Korea

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

AI generated plenty of interest at JPM but not a lot of trust

FDA seeking to stop procedures at two unregulated stem cell clinics

Francis Collins on trust in science and how Covid communications failed

Francis Collins on trust in science and how Covid communications failed

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

The cancer drug shortage isn’t new — and neither are the solutions

Twill hunts for pharma partner to market its depression app

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Test for long Covid? Researchers find new clue in blood samples

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Think you might have Covid

Trump demands the U.S. pay no more for drugs than other countries … again

FDA seeking to stop procedures at two unregulated stem cell clinics

Wikipedia

EU regulator recommends expanding Mounjaro approval to obesity

FDA seeking to stop procedures at two unregulated stem cell clinics

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

More hospitals are billing patients as online messages surge

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

NIH director takes cautious approach to Biden drug pricing priority

Wikipedia

focus

leisure time

entertainment